Back to Treatments

Treatment

Inotuzumab Ozogamicin

1
Conditions
50
Trials
5,000
Participants
35%
Average Safety

Condition Evidence

Acute lymphoid leukemia

50 trials · 5,000 participants

80% effectiveness · 35% safety
Inotuzumab Ozogamicin | DFDA